Trofinetide Patent Expiration

Trofinetide is Used for treating Rett Syndrome or its symptoms. It was first introduced by Acadia Pharmaceuticals Inc in its drug Daybue on Mar 10, 2023.

Trofinetide Patents

Given below is the list of patents protecting Trofinetide, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Daybue US11370755 Compositions of trofinetide Aug 03, 2040 Acadia Pharms Inc
Daybue US9212204 Treatment of rett syndrome using glycyl-L-2-methylprolyl-L-glutamic acid Jan 27, 2032 Acadia Pharms Inc

Coming Soon

Patent Strength Analyzer

Will this be useful for you?


Thank you for your response 🥳